TrialCancer medicine2020

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma.

Jack Patrick Gleeson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.